Book

Description

Advances in CAR-Based Therapeutics in Immunity and Oncology presents a comprehensive and cutting-edge overview of Chimeric Antigen Receptor (CAR) technology as it revolutionizes modern medicine. Bridging the fields of immunology, oncology, and cellular engineering, this volume explores the latest innovations in CAR-T, CAR-NK, and next-generation immune cell therapies. Leading experts examine the design, function, and clinical applications of CAR-modified cells, highlighting their transformative impact in treating hematologic malignancies, solid tumors, and immune-related disorders. With in-depth discussions on preclinical breakthroughs, translational challenges, regulatory considerations, and emerging therapeutic platforms, this book serves as an essential reference for clinicians, researchers, and biotechnology professionals at the forefront of immunotherapy. Whether you're exploring the promise of allogeneic CAR therapies, bispecific CARs, or armored immune cells, this volume provides critical insights into the future of personalized and precision medicine.